Service de Pneumologie, CHUV
Lausanne, Canton of Vaud, 1011, Switzerland
NCT Number: NCT04729920
With this cross-sectional study of adult subjects with neuromuscular disease in the French-speaking part of Switzerland, we aim to explore MI-E adherence using self-report questionnaires and device data in order to identify the factors that influence the pattern of MI-E use and satisfaction with the treatment. Determining potential barriers to regular long-term home use of MI-E could help in identifying the patients who would benefit most from this therapy.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lausanne, Canton of Vaud, 1011, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-Invasive airway
download of device (MI-E) data and self-reported satisfaction with the device
Time frame: 12 months, or since treatment initiation (> 3 months)
based on self-reported use
Time frame: 12 months, or since treatment initiation (> 3 months)
based on data downloads
Time frame: 12 months, or since treatment initiation (> 3 months)
Self-report questionnaire
Centre Hospitalier Universitaire Vaudois
Other
Predictors of Home Use of Mechanical Insufflation/Exsufflation Devices in Neuromuscular Patients: a Cross-sectional Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05798325
Nervous System Diseases, Neuromuscular Diseases
Paris, France
View Trial DetailsNCT06367686
Apnea, Chronic Disease
Tønsberg, Norway
View Trial DetailsNCT05070624
Nervous System Diseases, Neuromuscular Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT02789059
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Amiens, France
View Trial Details